Related Experiment Video
Updated: Jan 14, 2026
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11.7K
Optimal Diuretic Strategies for Chronic Heart Failure
Satoshi Shoji1, Martin Osorio Nader2, Robert J Mentz3
1Department of Medicine, Duke Clinical Research Institute, Durham, NC, USA; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
The Medical Clinics of North America
|October 24, 2025
Summary
Loop diuretics manage chronic heart failure congestion but their impact on survival is unclear. Personalized monitoring and optimizing guideline-directed medical therapy (GDMT) are key to effective diuretic use and improved patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Loop diuretics are recommended for chronic heart failure (CHF) congestion.
- Evidence on their impact on morbidity and mortality in CHF is limited.
- Current guidelines advocate for the lowest effective dose and individualized care.
Purpose of the Study:
- To explore strategies for optimizing loop diuretic use in CHF.
- To highlight the role of personalized monitoring in managing CHF.
- To investigate the integration of guideline-directed medical therapy (GDMT) with diuretic management.
Main Methods:
- Review of current guidelines and evidence regarding loop diuretic use in CHF.
- Emphasis on personalized monitoring including clinical, biomarker, and hemodynamic parameters.
- Discussion of optimizing GDMT components like ARNIs, SGLT2 inhibitors, and MRAs.
Main Results:
- The precise impact of loop diuretics on CHF morbidity and mortality requires further large-scale investigation.
- Individualized patient monitoring is crucial for effective diuretic management.
- Optimizing GDMT may enable reduction in loop diuretic dosage.
Conclusions:
- Integrating optimized GDMT with tailored monitoring strategies can enhance loop diuretic efficacy.
- Improved loop diuretic management through personalized care may lead to better clinical outcomes in CHF.
- Further research is needed to clarify the long-term effects of loop diuretics on CHF prognosis.
Keywords:
Chronic heart failureFurosemideGuideline-directed medical therapyLoop diureticLowest effective doseMonitoringTorsemideMore Related Videos
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796
01:30Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
01:22Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
01:16Antihypertensive Drugs: Action of Diuretics
2.2K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.2K
01:22Heart Failure Drugs: β-Blockers
760
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
760